Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Vebicorvir plus NRTI bij virologisch onderdrukte patiënten met chronische HBV
nov 2022 | Hepatitis, Hepatologie